Case number 2020-1417
Takeda Pharmaceuticals U.S.A. v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 8, 2020 | 20 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [720031] [20-1407, 20-1417] [JAB] [Entered: 09/08/2020 11:37 AM] (1) |
| Jul 31, 2020 | 18 | OPINION filed for the court by Prost, Chief Judge; Newman, Circuit Judge and Hughes, Circuit Judge. Dissenting opinion filed by Circuit Judge Newman. Precedential Opinion. [711531] [20-1407, 20-1417] [JAB] [Entered: 07/31/2020 09:56 AM] (24) |
| Jul 31, 2020 | 19 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [711532] [20-1407, 20-1417] [JAB] [Entered: 07/31/2020 09:57 AM] (1) |
| Apr 3, 2020 | 17 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Mylan Pharmaceuticals Inc., Entry of Appearance [16], is not in compliance with the rules of this court (see attached). Service as of this date by the Clerk of Court. [683956] [LMN] [Entered: 04/03/2020 10:46 AM] (1) |
| Apr 2, 2020 | 16 | Entry of appearance for Stu A. Williams as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 04/02/2020 by email. [683888] [20-1417] [Stu Williams] [Entered: 04/02/2020 10:10 PM] (1) |
| Feb 19, 2020 | 14 | ORDER consolidating the appeals. The revised official caption is reflected above. One set of briefs should be filed for the two appeals. Takeda's opening brief remains due no later than February 19, 2020. Service as of this date by the Clerk of Court. [672520] [20-1407, 20-1417] [LMS] [Entered: 02/19/2020 03:33 PM] (2) |
| Feb 19, 2020 | 15 | Note to file: The following cases are associated:20-1407 (Lead) with 20-1417 (Member Case). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [672567] [20-1407, 20-1417] [TAM] [Entered: 02/19/2020 04:33 PM] (0) |
| Feb 13, 2020 | 8 | Entry of appearance for Michael S. Sommer as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671177] [20-1417] [Michael Sommer] [Entered: 02/13/2020 04:45 PM] (1) |
| Feb 13, 2020 | 9 | Certificate of Interest for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671178] [20-1417] [Michael Sommer] [Entered: 02/13/2020 04:46 PM] (3) |
| Feb 13, 2020 | 10 | Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671179] [20-1417] [Michael Sommer] [Entered: 02/13/2020 04:47 PM] (4) |
| Feb 13, 2020 | 11 | Entry of appearance for Jessica L. Margolis as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671181] [20-1417] [Jessica Margolis] [Entered: 02/13/2020 04:49 PM] (1) |
| Feb 13, 2020 | 12 | Entry of appearance for Sheryl Shapiro Bassin as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671182] [20-1417] [Sheryl Shapiro Bassin] [Entered: 02/13/2020 04:51 PM] (1) |
| Feb 13, 2020 | 13 | Entry of appearance for Shyamkrishna Palaiyanur as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671183] [20-1417] [Shyamkrishna Palaiyanur] [Entered: 02/13/2020 04:53 PM] (1) |
| Feb 12, 2020 | 2 | Entry of appearance for Edgar H. Haug as principal counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670834] [20-1417] [Edgar Haug] [Entered: 02/12/2020 03:34 PM] (2) |
| Feb 12, 2020 | 3 | Entry of appearance for Porter F. Fleming as of counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670836] [20-1417] [Porter Fleming] [Entered: 02/12/2020 03:37 PM] (2) |
| Feb 12, 2020 | 4 | Entry of appearance for Jonathan A. Herstoff as of counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670838] [20-1417] [Jonathan Herstoff] [Entered: 02/12/2020 03:38 PM] (2) |
| Feb 12, 2020 | 5 | Entry of appearance for Camille Y. Turner as of counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670840] [20-1417] [Jonathan Herstoff] [Entered: 02/12/2020 03:40 PM] (2) |
| Feb 12, 2020 | 6 | Certificate of Interest for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670842] [20-1417] [Edgar Haug] [Entered: 02/12/2020 03:42 PM] (3) |
| Feb 12, 2020 | 7 | Docketing Statement for the Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670844] [20-1417] [Edgar Haug] [Entered: 02/12/2020 03:43 PM] (4) |
| Jan 31, 2020 | 1 | Appeal docketed. Received: 01/28/2020. [667547]Entry of Appearance due 02/14/2020. Certificate of Interest is due on 02/14/2020. Docketing Statement due 02/14/2020. Appellant's brief is due 03/31/2020. [TAM] [Entered: 01/31/2020 09:43 AM] (24) |
